title: Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation.
abstract: Interleukin (IL)-23 and IL-27 are IL-6/IL-12 family members that play a role in the regulation of T helper 1 cell differentiation. Cytokines are known to be involved in the bone remodeling process, although the effects of IL-23 and IL-27 have not been clarified. In this study, we examined the possible roles of these cytokines on osteoblast phenotypes and osteoclastogenesis. We found that IL-27 induced signal transducers and activators of transcription 3 activation in osteoblasts. However, neither IL-23 nor IL-27 showed any significant effects on alkaline phosphatase activity, receptor activator of nuclear factor kappaB ligand (RANKL) expression, mRNA expression such as alkaline phosphatase type I procollagen, or the proliferation of osteoblasts. Osteoclastogenesis from bone marrow cells induced by soluble RANKL was partially inhibited by IL-23 and IL-27 with reduced multinucleated cell numbers, but these interleukins did not affect the proliferation of osteoclast progenitor cells. These results indicate that IL-23 and IL-27 could partly modify cell fusion or the survival of multinucleated osteoclasts. On the other hand, partially purified T cells, which are activated by 2 microg/ml anti-CD3 antibody, completely inhibited osteoclastogenesis by M-CSF/RANKL. On using T cells activated with 0.2 microg/ml anti-CD3 antibody, in which osteoclastogenesis was partially inhibited, the interleukins had additive effects for inhibiting osteoclastogenesis. Although the consequences of phosphorylated signals in osteoblasts have not been identified, IL-23 and IL-27, partly and indirectly through activated T cells, inhibited osteoclastogenesis, indicating that these interleukins may protect against bone destructive autoimmune disorders.
authors: Department of Clinical Sciences, Josai International University, 1 Gumyo, Togane, Chiba 283-8555, Japan. kamiyas@jiu.ac.jp
authors: Sadahiro
authors: S
authors: Kamiya
authors: Chika
authors: C
authors: Nakamura
authors: Takeshi
authors: T
authors: Fukawa
authors: Katsuhiro
authors: K
authors: Ono
authors: Toshiyuki
authors: T
authors: Ohwaki
authors: Takayuki
authors: T
authors: Yoshimoto
authors: Seiki
authors: S
authors: Wada
mesh_terms: D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D015153:Blotting, Western; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D015870:Gene Expression / Q000187:drug effects; D005994:Glycerophosphates / Q000494:pharmacology; D007371:Interferon-gamma / Q000235:genetics / Q000378:metabolism; D020381:Interleukin-17 / Q000494:pharmacology*; D053759:Interleukin-23 / Q000494:pharmacology*; D051379:Mice; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects; D010010:Osteoclasts / Q000166:cytology* / Q000187:drug effects; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D053246:Receptor Activator of Nuclear Factor-kappa B / Q000235:genetics / Q000378:metabolism; D018123:Receptors, Interleukin / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors
chemical_list: D005994:Glycerophosphates; D020381:Interleukin-17; D053759:Interleukin-23; D012333:RNA, Messenger; D053246:Receptor Activator of Nuclear Factor-kappa B; D018123:Receptors, Interleukin; D007371:Interferon-gamma; D001205:Ascorbic Acid; C031463:beta-glycerophosphoric acid
references: Biochem Biophys Res Commun. 2000 Sep 7;275(3):768-75
references: 10973797
references: J Bone Miner Res. 2001 Oct;16(10):1754-64
references: 11585338
references: Immunity. 2002 Jun;16(6):779-90
references: 12121660
references: Nat Immunol. 2006 Sep;7(9):937-45
references: 16906166
references: J Clin Invest. 1999 May;103(9):1345-52
references: 10225978
references: Endocrinology. 1988 Apr;122(4):1373-82
references: 3345718
references: J Biol Chem. 2005 Mar 25;280(12):11759-69
references: 15653694
references: J Interferon Cytokine Res. 2003 Sep;23(9):513-22
references: 14565860
references: Nature. 2000 Nov 30;408(6812):600-5
references: 11117749
references: J Biol Chem. 2003 Jan 17;278(3):1910-4
references: 12417590
references: J Immunol. 2003 May 15;170(10 ):4886-90
references: 12734330
references: J Immunol. 2004 Dec 15;173(12):7170-82
references: 15585838
references: J Immunol. 2004 Feb 15;172(4):2225-31
references: 14764690
references: Nat Immunol. 2002 Jun;3(6):549-57
references: 12006974
references: J Immunol. 2005 Dec 1;175(11):7419-24
references: 16301649
references: J Virol. 2004 Sep;78(17):9093-104
references: 15308705
references: Blood. 2003 Aug 1;102(3):1078-86
references: 12689929
references: J Immunol. 2004 Aug 15;173(4):2479-85
references: 15294962
references: Nature. 2004 Apr 15;428(6984):758-63
references: 15085135
references: Nat Immunol. 2006 Sep;7(9):929-36
references: 16906167
references: J Exp Med. 1997 Mar 17;185(6):1005-12
references: 9091574
references: J Immunol. 2002 Jun 1;168(11):5699-708
references: 12023369
references: Endocr J. 2002 Aug;49(4):483-95
references: 12402981
references: Infect Immun. 2003 Jan;71(1):354-64
references: 12496185
references: Immunity. 2000 Nov;13(5):715-25
references: 11114383
references: J Immunol. 2006 Mar 1;176(5):2773-80
references: 16493033
references: J Exp Med. 2005 Sep 5;202(5):589-95
references: 16147974
references: J Immunol. 2002 Sep 15;169(6):3353-62
references: 12218157
references: J Biol Chem. 1999 Jul 2;274(27):19301-8
references: 10383440
references: J Bone Miner Res. 1998 May;13(5):777-85
references: 9610741
references: J Immunol. 2004 Sep 15;173(6):3871-7
references: 15356135
references: Cell. 1996 Feb 9;84(3):431-42
references: 8608597
references: Cancer Res. 2004 Feb 1;64(3):1152-6
references: 14871851
references: J Immunol. 2005 Aug 1;175(3):1686-93
references: 16034109
references: J Immunol. 2006 Jun 15;176(12):7317-24
references: 16751375